KPC Pharmaceuticals Inc (600422) — Capital Reinvestment Ratio
Latest as of June 2025:
0.04x
KPC Pharmaceuticals Inc (600422) has a Capital Reinvestment Ratio of 0.04x as of June 2025, meaning it reinvests 0% of its operating cash flow (CN¥358.28 Million) in capital expenditures (CN¥13.08 Million). See KPC Pharmaceuticals Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.04x
Capex / Operating Cash Flow
Operating Cash Flow
CN¥358.28 Million
CNY
Capital Expenditures
CN¥13.08 Million
CNY
Data as of
Jun 2025
Most recent filing
KPC Pharmaceuticals Inc Capital Reinvestment Ratio (1999–2024)
This chart tracks KPC Pharmaceuticals Inc's Capital Reinvestment Ratio across 24 annual periods.
Annual Capital Reinvestment Ratio for KPC Pharmaceuticals Inc (1999–2024)
Year-by-year Capital Reinvestment Ratio for KPC Pharmaceuticals Inc from 1999 to 2024. For live market cap and broader valuation context, see 600422 market cap overview.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.10x | CN¥808.07 Million | CN¥79.43 Million | ▼ -46.5% |
| 2023 | 0.18x | CN¥356.08 Million | CN¥65.48 Million | ▼ -54.1% |
| 2022 | 0.40x | CN¥253.90 Million | CN¥101.75 Million | ▼ -57.3% |
| 2021 | 0.94x | CN¥251.63 Million | CN¥236.17 Million | ▲ +142.4% |
| 2020 | 0.39x | CN¥409.94 Million | CN¥158.73 Million | ▼ -52.1% |
| 2019 | 0.81x | CN¥429.50 Million | CN¥347.35 Million | ▲ +31.1% |
| 2018 | 0.62x | CN¥352.07 Million | CN¥217.26 Million | ▼ -44.3% |
| 2017 | 1.11x | CN¥242.53 Million | CN¥268.74 Million | ▲ +69.5% |
| 2016 | 0.65x | CN¥311.16 Million | CN¥203.45 Million | ▲ +47.8% |
| 2015 | 0.44x | CN¥476.62 Million | CN¥210.82 Million | ▼ -24.8% |
| 2014 | 0.59x | CN¥379.13 Million | CN¥222.98 Million | ▼ -33.1% |
| 2013 | 0.88x | CN¥241.97 Million | CN¥212.65 Million | ▲ +52.2% |
| 2012 | 0.58x | CN¥213.33 Million | CN¥123.22 Million | ▲ +89.0% |
| 2011 | 0.31x | CN¥140.24 Million | CN¥42.85 Million | ▼ -56.7% |
| 2010 | 0.71x | CN¥90.82 Million | CN¥64.16 Million | ▲ +382.6% |
| 2009 | 0.15x | CN¥128.57 Million | CN¥18.82 Million | ▲ +2.4% |
| 2008 | 0.14x | CN¥91.59 Million | CN¥13.09 Million | ▲ +11.5% |
| 2007 | 0.13x | CN¥130.06 Million | CN¥16.67 Million | ▼ -73.0% |
| 2006 | 0.47x | CN¥61.25 Million | CN¥29.03 Million | ▼ -9.5% |
| 2003 | 0.52x | CN¥61.23 Million | CN¥32.08 Million | ▼ -88.6% |
| 2002 | 4.58x | CN¥17.38 Million | CN¥79.62 Million | ▲ +1594.6% |
| 2001 | 0.27x | CN¥67.07 Million | CN¥18.13 Million | ▼ -46.7% |
| 2000 | 0.51x | CN¥47.76 Million | CN¥24.20 Million | ▲ +141.1% |
| 1999 | 0.21x | CN¥60.24 Million | CN¥12.67 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow